Corcept Therapeutics Inc. (CORT)

Last Three Months

17-Feb-21 -- 16-May-21

Time Period:
  • Three Months
  •  | 
  • Year

($1.65M) Net Amount
Buy:0--
Sell:($1.65M)$23.88 - $25.21

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Hold
Insider Trading Sentiment: Hold
Insider Trading Sentiment: Hold
Sentiment Breakdown by Insider
0
(3)
1
(2)
0
(1)
33
0
2
+1
0
+2
0
+3

Two Year Chart

17-May-19 -- 16-May-21

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Last TransactionLast Three Months
SEC FilingTransactionInsiderSentimentCompanyHoldings ChangeBuy AmountSell AmountBuy Price RangeSell Price Range
16-Apr-21 10:00 PM
View: 
14-Apr-21
Disposition (other)
0
Wilson James N
Director
Insider Trading Sentiment for Wilson James N at Corcept Therapeutics Inc. (CORT):Corcept Therapeutics Inc. - CORT6%
1.97M to 2.08M
0
0
---- Show TxnsShow Insider Trades
13-May-21 5:40 PM
View: 
11-May-21
Payment of Exercise
($132.60K)
Mahoney David L
Director
Insider Trading Sentiment for Mahoney David L at Corcept Therapeutics Inc. (CORT):Corcept Therapeutics Inc. - CORT12%
201.48K to 225.0K
0
0
---- Show TxnsShow Insider Trades
07-Apr-21 5:20 PM
View: 
05-Apr-21
Market Option Sale (Planned)
($181.04K)
Insider Trading Sentiment for Swisher Daniel N Jr at Corcept Therapeutics Inc. (CORT):Corcept Therapeutics Inc. - CORT0%
--
0
($181.04K)
(100%)
--$24.14 Show TxnsShow Insider Trades
05-Apr-21 5:12 PM
View: 
01-Apr-21
Market Option Sale
($597.03K)
Lyon Joseph Douglas
Chief Accounting Officer
Insider Trading Sentiment for Lyon Joseph Douglas at Corcept Therapeutics Inc. (CORT):Corcept Therapeutics Inc. - CORT0%
--
0
($1.23M)
(100%)
--$23.88 - $25.21 Show TxnsShow Insider Trades
27-Apr-21 6:30 PM
View: 
23-Apr-21
Market Sale (Planned)
($240.22K)
Robb Gary Charles
Chief Financial Officer
Insider Trading Sentiment for Robb Gary Charles at Corcept Therapeutics Inc. (CORT):Corcept Therapeutics Inc. - CORT(11%)
90.2K to 80.2K
0
($240.22K)
(11%)
--$24.02 Show TxnsShow Insider Trades